30 What are the Dominant Radiobiological Mechanisms at Play in Stereotactic Radiotherapy?  by Brenner, D.J. & Shuryak, I.
ICTR-PHE 2016  S15 
 
behaviors by the Porsolt forced swim test, and locomotor 
activity and anxiety by the open field test. We also studied 
adult neurogenesis within the hippocampal dentate gyrus by 
using the thymidine analogue BrdU to label replicating stem 
cells. Ten months after irradiation animals were killed and 
brain tissue used for histology and immunohistochemistry.  
Results: Microbeam irradiation did not alter cognitive 
performance. Interestingly, microbeam irradiation (300 Gy) 
significantly reduced the immobility time in the forced swim 
test without affecting locomotor activity as compared to 
control rats and 5-10 Gy irradiated rats. Histological analysis 
showed that microbeam irradiation did not alter the 
cytoarchitecture of the hippocampus with cell death 
observed only along the irradiation pathway. We did not 
observe a reduction of hippocampal neurogenesis, assessed 
by stereological counts of BrdU-positive cells in the dentate 
gyrus of the hippocampus at 10 months after microbeam 
irradiation.  
Conclusions: These data shed light on the biological effects 
of microbeam irradiation on the CNS and may open new 
potential therapeutic strategies in cancer treatment and 
other CNS disorders. 
Keywords: Microbeam radiation therapy, Hippocampus, 
Neurogenesis  
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Recent clinical results using Stereotactic Radiation Therapy 
(SRT) are very encouraging. Our goal is to investigate 
whether the excellent SRT tumor control data imply that 
there are new tumoricidal mechanisms that determine tumor 
control at high SRT doses – new mechanisms which are not 
present or have little effect at conventional radiotherapeutic 
doses.  
To accomplish this, we investigate whether the standard LQ 
model with heterogeneity can provide as good a description 
of the SRT data as can models with extra terms describing 
unique high-dose tumor control mechanisms. 
We analyzed published TCP data for lung tumors or brain 
metastases from 3000 SRT patients, covering a wide range of 
doses and fraction numbers. We used: (a) a linear-quadratic 
model (including heterogeneity), which assumes the same 
mechanisms at all doses, and (b) alternative models with 
terms describing distinct tumoricidal mechanisms at high 
doses. 
Both for lung and brain data, the LQ model provided a 
significantly better fit over the entire range of treatment 
doses than did any of the models requiring extra terms at 
high doses. Analyzing the data as a function of fractionation 
(1 fraction vs. >1 fraction), there was no significant effect on 
TCP in the lung data, whereas for brain data multi-fraction 
SRT was associated with higher TCP than single-fraction 
treatment. 
This analysis suggests that distinct tumoricidal mechanisms 
do not determine tumor control at high doses/fraction. 
Rather the excellent clinical outcomes seen with SRT are the 
result of the excellent dose distributions which SRT provides, 
which allow delivery of larger doses to the tumor than is 
possible with conventional radiotherapy. Finally, there is 
plausible evidence suggesting that multi-fraction SRT is 
superior to single-dose SRT. 
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Purpose: Image-guided radiotherapy (IGRT) is a technique 
used to optimise RT beam delivery to the tumour by 
following its evolution over time through regular MVCT 
imaging of the treatment area. 
However, its application is limited by clinical concerns over 
the additional dose coming from MVCT imaging, which we 
evaluate in this study. 
Methods: We use the particle transport framework GEANT4[1] 
to model the X-ray beam line from the Tomotherapy Hi-Art 
RT treatment machine at the Addenbrooke's hospital and 
evaluate the imaging dose delivered to the vicinity of the 
tumour. Dose maps are obtained by combining simulations of 
the CT scan using a static beam line with 51 different 
exposition angles. 
All GEANT4 simulations were performed on UK grid 
resources[2] to maximize parallel throughput, using 
anonymised data. 
Results: Simulated beam profiles (PDD, longitudinal and 
lateral) with different MLC beam patterns were compared to 
actual calibration data taken in water tank at Addenbrooke's 
hospital. The agreement between the model and the 
calibration is quantified by the Gamma index[3]. Less than 2% 
of the simulated points exceed Gamma(1%,1mm) 
We also simulated the imaging dose distribution in a prostate 
patient treated in 34 fractions, each fraction starting with 
one MV CT used for image guidance. We used a fan beam 
width of 4 mm with a pitch of 2 mm. The results are shown in 
Figure 1. 
 
 
Figure 1: Normalised imaging dose distributions in Gy for a 
prostate cancer patient, in a transverse plane in the 
treatment region. 
 
The maximum simulated dose is about 1.5 cGy on a single 
MVCT, in agreement with results found in [4] using 
proprietary software. For comparison, the treatment dose in 
the same area goes up to 2 Gy per fraction. 
Conclusions: We have successfully modeled the Megavoltage 
imaging beam line of the Tomotherapy Hi-Art machine used 
for radiotherapy at the Addenbrooke's hospital using Geant 4 
and used it to derive dose maps in the patient. 
Doses were found to be in agreement with other published 
results and negligible with respect to the treatment dose. 
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